Close Menu

protein biomarkers

C4BPA could prove useful as a diagnostic biomarker for early stage pancreatic cancer and to help differentiate the disease from other cancers.

The test could provide an early diagnosis of breast cancer by examining a handful of miRNA, microRNA, and proteomic biomarkers from urine samples. 

Three Markers

A Queen Mary University of London-led team reports on a three-protein biomarker panel for early stage pancreatic cancer.

The firm's approach builds on a pilot study for ISB's 100K Wellness Project, and study participants are invited to become customers.

Investigators from SomaLogic and elsewhere found proteins whose expression levels vary in Duchenne muscular dystrophy, often in conjunction with patients' age.

ViveBio plans to develop an assay based on inflammatory protein and mRNA biomarkers for laboratory-developed and companion diagnostic testing.

Protagen announced a long-term collaboration agreement with Qiagen to provide pharmaceutical partners access to technology that would advance the development of protein-based companion tests for autoimmune disorders.

NEW YORK (GenomeWeb) – The plasma levels of a number of disease biomarkers are influenced by genetic and lifestyle factors, a new study in Nature Communications reported today.

NEW YORK (GenomeWeb) – BHC Center of Financial and Investment Business today announced it has invested in 20/20 GeneSystems to help bring the company's diagnostic test for lung cancer to China.

NEW YORK (GenomeWeb) – The National Institutes of Health will award $1.5 million for research to find protein biomarkers that could be used to identify and treat chronic brain injuries (CBI), the long-term effects of traumatic brain injuries.

Pages

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational biologist James Taylor has died, according to Johns Hopkins University.

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.